Extendicare (TSE:EXE – Get Free Report) had its price target boosted by equities researchers at National Bank Financial from C$34.00 to C$40.00 in a research report issued on Wednesday,BayStreet.CA reports. The firm presently has an “outperform” rating on the stock. National Bank Financial’s price objective would suggest a potential upside of 20.26% from the company’s previous close.
A number of other research firms have also issued reports on EXE. TD boosted their price objective on Extendicare from C$32.00 to C$39.00 and gave the company a “buy” rating in a research note on Monday, May 11th. Desjardins set a C$34.50 price objective on Extendicare and gave the company a “buy” rating in a research note on Wednesday, April 22nd. Canaccord Genuity Group upgraded Extendicare to a “strong-buy” rating in a research note on Monday, May 11th. BMO Capital Markets boosted their price objective on Extendicare from C$30.00 to C$38.00 in a research note on Wednesday, May 13th. Finally, TD Securities upgraded Extendicare from a “hold” rating to a “buy” rating and boosted their price objective for the company from C$19.00 to C$32.00 in a research note on Monday, April 6th. Two analysts have rated the stock with a Strong Buy rating and six have given a Buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of C$32.56.
Check Out Our Latest Stock Report on Extendicare
Extendicare Stock Performance
Extendicare (TSE:EXE – Get Free Report) last released its quarterly earnings data on Thursday, May 7th. The company reported C$0.42 earnings per share (EPS) for the quarter. Extendicare had a return on equity of 45.35% and a net margin of 6.99%.The company had revenue of C$465.22 million for the quarter. On average, equities analysts expect that Extendicare will post 0.6134729 earnings per share for the current year.
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Stories
- Five stocks we like better than Extendicare
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
- Zscaler Stock Drops 30%: Why the Dip Is a Buy Opportunity
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
